Comparison of Cardioplegic Solutions in Coronary Bypass Surgery

A clinical study comparing Custodiol and Blood cardioplegia solutions on myocardial tissue samples from coronary bypass surgery patients. The research evaluates gene expression levels of autophagy and apoptosis markers, including BECLIN and CASPASE 3, 8, and 9, before and after aortic cross-clamping. The dataset likely contains molecular-level measurements from patient samples, authored by Elif Funda Şener and published as Open Access research.

Use Cases

• Compare the effects of different cardioplegia solutions based on gene expression data.
• Analyze the relationship between autophagy and apoptosis markers in myocardial tissue based on the described BECLIN and CASPASE measurements.
• Train models to predict postoperative Troponin T levels based on intraoperative molecular markers.
• Investigate the molecular mechanisms of myocardial protection during cardiac surgery based on the described experimental design.

Strengths

• Study design includes pre- and post-intervention tissue samples from each patient, allowing for paired analysis.
• Statistical significance levels (p-values) for key findings, such as BECLIN gene expression (p=0.0078), are reported.

Limitations

• Row count and dataset scale are unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset's freshness is unverified as the last update date is unknown.

Provenance

Source

Elif Funda Şener

Collection Method

Clinical trial involving two patient groups administered different cardioplegia solutions, with myocardial tissue samples collected during surgery.